DIAGNOS OTC Stock Top Insiders
| DGNOF Stock | USD 0.22 0.01 4.35% |
DIAGNOS employs about 18 people. The company is managed by 4 executives with a total tenure of roughly 36 years, averaging almost 9.0 years of service per executive, having 4.5 employees per reported executive. Examination of DIAGNOS's management performance can provide insight into the company performance.
| Andre Larente CEO CEO and President and Executive Director |
| Guillermo Robles President Vice President - Health Care Business Development of Latin America |
DIAGNOS |
DIAGNOS Management Team Effectiveness
The company has return on total asset (ROA) of (1.2131) % which means that it has lost $1.2131 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (24.5157) %, meaning that it generated substantial loss on money invested by shareholders. DIAGNOS's management efficiency ratios could be used to measure how well DIAGNOS manages its routine affairs as well as how well it operates its assets and liabilities.DIAGNOS secures a total of 69.47 Million outstanding shares. DIAGNOS owns 16.34 % of its outstanding shares held by insiders and 0.0 % owned by institutions. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in otc stocks such as DIAGNOS in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of DIAGNOS, and when they decide to sell, the otc stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
DIAGNOS Workforce Comparison
DIAGNOS is rated # 3 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 474. DIAGNOS holds roughly 18.0 in number of employees claiming about 4% of equities under Health Care industry.
DIAGNOS Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. DIAGNOS Price Series Summation is a cross summation of DIAGNOS price series and its benchmark/peer.
DIAGNOS Notable Stakeholders
A DIAGNOS stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DIAGNOS often face trade-offs trying to please all of them. DIAGNOS's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DIAGNOS's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Andre Larente | CEO and President and Executive Director | Profile | |
| Guillermo Robles | Vice President - Health Care Business Development of Latin America | Profile | |
| Martin Beland | Director Marketing | Profile | |
| MarcAndr Massue | CFO Fin | Profile |
About DIAGNOS Management Performance
The success or failure of an entity such as DIAGNOS often depends on how effective the management is. DIAGNOS management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DIAGNOS management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DIAGNOS management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company was founded in 1998 and is headquartered in Brossard, Canada. Diagnos operates under Health Information Services classification in the United States and is traded on OTC Exchange.
The data published in DIAGNOS's official financial statements typically reflect DIAGNOS's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving DIAGNOS's quantitative information. For example, before you start analyzing numbers published by DIAGNOS accountants, it's essential to understand DIAGNOS's liquidity, profitability, and earnings quality within the context of the Health Care Technology space in which it operates.
DIAGNOS Workforce Analysis
Traditionally, organizations such as DIAGNOS use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DIAGNOS within its industry.DIAGNOS Manpower Efficiency
Return on DIAGNOS Manpower
| Revenue Per Employee | 24.4K | |
| Revenue Per Executive | 109.7K | |
| Net Loss Per Employee | 144.9K | |
| Net Loss Per Executive | 652.1K |
Complementary Tools for DIAGNOS OTC Stock analysis
When running DIAGNOS's price analysis, check to measure DIAGNOS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DIAGNOS is operating at the current time. Most of DIAGNOS's value examination focuses on studying past and present price action to predict the probability of DIAGNOS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DIAGNOS's price. Additionally, you may evaluate how the addition of DIAGNOS to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |